| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
PI3K-IN-10 manufacturers
- PI3K-IN-10
-
-
2026-07-27
- CAS:2211922-64-2
- Purity:
- Supply Ability: 10g
- PI3K-IN-10
-
-
2026-07-27
- CAS:2211922-64-2
- Purity:
- Supply Ability: 10g
- PI3K-IN-10
-
-
2025-07-26
- CAS:2211922-64-2
- Purity:
- Supply Ability: 10g
|
| | PI3K-IN-10 Basic information |
| Product Name: | PI3K-IN-10 | | Synonyms: | PI3K-IN-10;PI-3K-IN-10,PI3K IN 10,PI3KIN10;Quinoline, 8-chloro-4-[4-(1H-imidazol-5-yl)-6-(4-morpholinyl)-1H-benzimidazol-1-yl]- | | CAS: | 2211922-64-2 | | MF: | C23H19ClN6O | | MW: | 430.89 | | EINECS: | | | Product Categories: | | | Mol File: | 2211922-64-2.mol |  |
| | PI3K-IN-10 Chemical Properties |
| Boiling point | 813.9±75.0 °C(Predicted) | | density | 1.49±0.1 g/cm3(Predicted) | | pka | 12.40±0.10(Predicted) |
| | PI3K-IN-10 Usage And Synthesis |
| Description | PI3K-IN-10 is a potent pan-PI3K inhibitor as a benzimidazole derivative. | | Uses | PI3K-IN-10 is a potent pan-PI3K inhibitor as a benzimidazole derivative, compound 332, extracted from patent WO2018057808A1[1]. | | IC 50 | PI3K | | References | [1] Jayaraman Chandrasekhar, et al. Benzimidazole derivatives and their use as phosphatidylinositol 3-kinase inhibitors. Patent WO2018057808A1. |
| | PI3K-IN-10 Preparation Products And Raw materials |
|